Piramal acquires Digeplex from Shreya Lifesciences
"We believe Digeplex and its associated brands are a strategic fit for our portfolio that will help us move closer towards our stated objective," executive director Nandini Piramal said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 30, 2017 Category: Pharmaceuticals Source Type: news

Cipla gets WHO nod to sell TB preventing drug in HIV patients
Q-TIB is a novel fixed dose combination in a single tablet and it is for the first time that such a combination has been made available in the world. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 30, 2017 Category: Pharmaceuticals Source Type: news

Healthcare's dilemma: Balancing public needs with business sense
With the scrutiny over quality and affordability of healthcare becoming a big issue, the question of balancing public needs with commercial aspirations have polarised the industry. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 29, 2017 Category: Pharmaceuticals Source Type: news

Government needs proactive approach to boost pharma sector: Industry
The Indian pharmaceutical industry, with current market size of USD 27.57 billion is expected to reach USD 55 billion by 2020 growing at a CAGR of 15.92 per cent. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 29, 2017 Category: Pharmaceuticals Source Type: news

Securities class action lawsuit served on Dr Reddy's in US
The lawsuit alleged that the company made materially false and/or misleading statements or omissions in connection with its corporate quality system, it had added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 29, 2017 Category: Pharmaceuticals Source Type: news

Nigeria new attraction for Indian pharma firms
With more than 60 per cent of the population falling within the working age of 15-64 years, this young workforce will be able to support the growth of Nigeria's services sector, McKinsey said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 29, 2017 Category: Pharmaceuticals Source Type: news

One in 10 medicines in developing countries is substandard or falsified: WHO
WHO has received reports of substandard or falsified medical products ranging from cancer treatment to contraception. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 28, 2017 Category: Pharmaceuticals Source Type: news

Glenmark Pharma gets 7 observations from USFDA for Baddi unit
Glenmark said its Baddi unit contributes approximately 10 per cent of the revenue of the US sales. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 28, 2017 Category: Pharmaceuticals Source Type: news

How India can make cheap and quality medicines available to all
They could procure medicines from any manufacturer complying with WHO current good manufacturing practices (cGMP) but would incur heavy penalties for repeated stock-outs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 28, 2017 Category: Pharmaceuticals Source Type: news

Regulatory actions won't stop growth of emerging markets, says Sanofi EVP
Emerging markets account for 7% of Sanofi ’s global revenues, driven by its limited product in rare diseases, diabetes and oncology segments. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 27, 2017 Category: Pharmaceuticals Source Type: news

Zydus gets USFDA nod for seizure, migraine drug
Zydus Cadila has more than 170 approvals and has so far filed over 310 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 27, 2017 Category: Pharmaceuticals Source Type: news

New chemotherapy delivery hits precise target
Having got a US patent in April this year, Kumar claims his precision-targeted drug delivery system is market-ready. “I think we will go into production in nine months. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 26, 2017 Category: Pharmaceuticals Source Type: news

Sun Pharma recalls two lots of diabetes drug due to microbial contamination
According to US FDA, a Class II recall occurs in a situation where use of or exposure to the product may lead to temporary or medically reversible adverse health consequences. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 25, 2017 Category: Pharmaceuticals Source Type: news

More life-saving medicines to become cheaper by as much as 53%
The National Pharmaceutical Pricing Authority (NPPA) on Friday fixed the maximum prices of 36 medicines and revised the ceiling prices of 15 others. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 24, 2017 Category: Pharmaceuticals Source Type: news

GST makes ‘orphan drugs’ prices soar
These high-value ‘orphan’ drugs used in bone marrow transplant, classical Hodgkin Lymphoma, Crohn’s disease and melanoma. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 24, 2017 Category: Pharmaceuticals Source Type: news

Biocon introduces oncologic biosimilar KRABEVA in India
The biosimilar product will be used for the treatment of patients with metastatic colorectal cancer and other types of lung, kidney, cervical, ovarian and brain cancers in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 23, 2017 Category: Pharmaceuticals Source Type: news

Will Indian drug exports to other countries get stuck in EU ports?
In 2008, 17 shipments (16 from India and one from China) were detained in Europe on grounds of infringement of intellectual property. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 23, 2017 Category: Pharmaceuticals Source Type: news

Strides arm gets USFDA nod for altitude sickness tablets
In a BSE filing, it said Strides Pharma Global Pte. has received approval from the United States Food and Drug Administration (USFDA) for Acteazolamide tablets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 22, 2017 Category: Pharmaceuticals Source Type: news

Pharma firms tide over GST impact
Pharma firms had seen their revenues negatively impacted in the first quarter due to destocking ahead of the GST implementation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 21, 2017 Category: Pharmaceuticals Source Type: news

Dr Reddy's gets EIR for Vizag plant, but inspection not closed
It, however, said the US Food and Drug Administration has not closed the inspection and the manufacturing site's status remains unchanged. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 21, 2017 Category: Pharmaceuticals Source Type: news

GSK Health names Navneet Saluja as India Sub-continent head
Saluja's last assignment with GSK Consumer Healthcare was that of Area General Manager in the Middle East and Africa. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 20, 2017 Category: Pharmaceuticals Source Type: news

Eris signs definitive pact to buy Strides ’ India portfolio for Rs 500 cr
The acquisition is Eris ’s fourth and the largest buyout in the last 18 months. With this, the company will be among the top ten companies in the Central Nervous System (CNS) segment. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 18, 2017 Category: Pharmaceuticals Source Type: news

Eris Life to acquire Strides' India business for Rs 500 crore
Boards of both the companies are expected to meet on Saturday and a formal announcement is due as early as on Monday, people with knowledge of the matter said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 17, 2017 Category: Pharmaceuticals Source Type: news

USFDA gives final approval to Cipla's anti-asthma product
Citing IMS Health data, Cipla said Pulmicort Respules and generic equivalents had US sales of approximately USD 825 million for the 12 months to September 2017. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 17, 2017 Category: Pharmaceuticals Source Type: news

Daiichi gave Delhi High Court wrong information: Singh brothers
Contrary to Daiichi's allegation that RHC had violated these orders, Dutt said the unencumbered shares of RHC in Religare have gone above what were undertaken in March. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 16, 2017 Category: Pharmaceuticals Source Type: news

USFDA issues warning letter to Lupin's Goa, Indore plants
On Lupin's Pithampur (Indore) plant, the US health regulator said the company invalidated initial OOS laboratory results without adequate investigations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 16, 2017 Category: Pharmaceuticals Source Type: news

Lenders of Orchid Pharma appoint Sripatham Ramkumar as resolution professional
Lakshmi Vilas Bank has referred Orchid Pharma to National Company Law Tribunal and the court had admitted the company on August 17. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 16, 2017 Category: Pharmaceuticals Source Type: news

Glenmark Pharmaceuticals launches nicotine gum Kwitz
Kwitz nicotine gum will be available in two variants of 2 mg as an OTC product 4mg as prescription product, the company said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 16, 2017 Category: Pharmaceuticals Source Type: news

Government need not consult statutory board to ban combo drugs: Supreme Court
The government challenged it in the top court on the ground that the ban was necessary in public interest, prompting the top court to stay the Delhi HC ’s order. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 15, 2017 Category: Pharmaceuticals Source Type: news

Daiichi Sankyo files fresh plea against Singh brothers
The Singh brothers ’ holding company RHC Holding has reduced its shareholding in Religare Enterprises in violation of the High Court’s order in March, Daiichi has alleged in its petition. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 15, 2017 Category: Pharmaceuticals Source Type: news

Fortis to buy realty assets back from RHT for Rs 4,650 crore
The healthcare chain has adopted the asset-light model whereby it had sold these assets to the trust and had taken them back on lease basis. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 15, 2017 Category: Pharmaceuticals Source Type: news

Fortis board clears RHT portfolio acquisition for Rs 4,650 cr
The healthcare chain has adopted the asset-light model whereby it had sold these assets to the trust and had taken them back on lease basis. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 15, 2017 Category: Pharmaceuticals Source Type: news

Hetero launches FDC combination of key HIV drugs
The FDC drug ‘Darunavir+Ritonavir’ is an anti-retroviral medication indicated for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 14, 2017 Category: Pharmaceuticals Source Type: news

DRL launches anti-cancer drug in US market
According to a statement issued by the city-based drug maker, its generic version of the injection is available in single-dose, 20 ml flint vials containing 20 mg of clofarabine in 20 ml of solution. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 14, 2017 Category: Pharmaceuticals Source Type: news

Lara Bezerra to take over as Roche Products India MD
Lara has over 24 years of experience in the pharmaceutical industry and was earlier the general manager of Roche Venezuela. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 14, 2017 Category: Pharmaceuticals Source Type: news

Only 'immaterial dent' due to FDA action: Lupin
The Mumbai-based company received two warning letters last week from the US Food and Drug Administration for its manufacturing units in Goa and Indore. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 13, 2017 Category: Pharmaceuticals Source Type: news

How PM Narendra Modi put new life in an ailing UPA scheme
Few had heard of Jan Aushadhi Scheme before September 2015, when the Modi-led government renamed it first as Pradhan Mantri Jan Aushadhi Yojana. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 11, 2017 Category: Pharmaceuticals Source Type: news

Zydus gets regulatory nod to market Lipaglyn in Mexico
The company has been granted marketing approval from the Mexican regulatory authority COFEPRIS to commercialise Lipaglyn in Mexico, Zydus said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 10, 2017 Category: Pharmaceuticals Source Type: news

Morepen inks pact with V ésale Pharma to boost presence in Rs 1000-crore probiotics market
Morepen, which currently does not have a presence in the probiotic market for gastroenterology, hopes to use its latest agreement to capture 5-10% of this segment by 2022. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 8, 2017 Category: Pharmaceuticals Source Type: news

Lupin gets warning letter from USFDA for Goa, Indore units
The company upholds quality and compliance issues with utmost seriousness and remains fully committed to be compliant with cGMP quality standards across all the facilities. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 7, 2017 Category: Pharmaceuticals Source Type: news

ET Analysis: With Unichem Buy, Torrent's new M & A star in pharma
This deal, coming in on reasonable valuations of nearly four times of revenues, propels Torrent to become the fifth largest player in the domestic market with a market share of 3.4%. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 6, 2017 Category: Pharmaceuticals Source Type: news

Torrent Pharma gets green nod for Rs 300 crore project
The Union environment ministry has asked the Ahmedabad-based firm to seek necessary approvals from the Gujarat state pollution control board. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 6, 2017 Category: Pharmaceuticals Source Type: news

This conventional businessman is set for second innings
An alumnus of Harvard University, Prakash Mody took over the reins of Unichem, started by his father Amrut Lal Mody in 1944, when the company just had one manufacturing unit. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 3, 2017 Category: Pharmaceuticals Source Type: news

Torrent Pharma walks away with Unichem ’s domestic business for Rs 3,600 crore
The deal will put Torrent among the country ’s top five drugmakers. It will will also give Torrent access to 120 brands of Unichem in India and Nepal. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 3, 2017 Category: Pharmaceuticals Source Type: news

Natco's partner Alvogen gets nod for influenza drug in US
In December last year, Alvogen launched the first generic equivalent to oseltamivir phosphate capsules in the United States. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 3, 2017 Category: Pharmaceuticals Source Type: news

Torrent may announce Unichem ’s domestic business buy today
Unichem promoted by pharma industry veteran Prakash Amrut Mody recorded domestic sales worth Rs 976 crore in the past ten months, with a 5% growth. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 2, 2017 Category: Pharmaceuticals Source Type: news

Lupin launches tablets in US to treat infections
The 75 mg and 150 mg tablets were launched after receiving the approval for the from the United States Food and Drug Administration (USFDA), Lupin said in a filing to BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 2, 2017 Category: Pharmaceuticals Source Type: news

Intas closing in on Mallinckrodt ’s US generics business
This comes as US President Donald Trump has declared opioid addiction a public health emergency in the US and drugmakers have found themselves under scrutiny. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 1, 2017 Category: Pharmaceuticals Source Type: news

US states sue 5 Indian generic drug makers over price cartelisation
Sun Pharma, Dr Reddy ’s , Emcure Pharma, Zydus Cadila and Glenmark Pharmaceuticals are among companies sued jointly by 45 US states. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 1, 2017 Category: Pharmaceuticals Source Type: news

Serum eyes Rs 10,000 crore revenues by 2022, unveils new vaccines
The company is also developing vaccine and drug for dengue fever. It has commenced first phase of trials in Singapore and hopes to launch vaccine in 2020. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 31, 2017 Category: Pharmaceuticals Source Type: news